![Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? | BMC Medicine | Full Text Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? | BMC Medicine | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1741-7015-10-20/MediaObjects/12916_2011_Article_505_Fig1_HTML.jpg)
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? | BMC Medicine | Full Text
![Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain - Civiero - 2015 - Journal of Neurochemistry - Wiley Online Library Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain - Civiero - 2015 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b26060f9-31ce-4359-8768-3dc89d3e8451/jnc13369-fig-0008-m.jpg)
Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain - Civiero - 2015 - Journal of Neurochemistry - Wiley Online Library
![Leucine-rich repeat kinase 2 (LRRK2) is expressed in dendritic cells... | Download Scientific Diagram Leucine-rich repeat kinase 2 (LRRK2) is expressed in dendritic cells... | Download Scientific Diagram](https://www.researchgate.net/publication/323013729/figure/fig4/AS:667766596055047@1536219371216/Leucine-rich-repeat-kinase-2-LRRK2-is-expressed-in-dendritic-cells-and-is.png)
Leucine-rich repeat kinase 2 (LRRK2) is expressed in dendritic cells... | Download Scientific Diagram
![Leucine-rich repeat kinase 2: A new player with a familiar theme for Parkinson's disease pathogenesis | PNAS Leucine-rich repeat kinase 2: A new player with a familiar theme for Parkinson's disease pathogenesis | PNAS](https://www.pnas.org/cms/10.1073/pnas.0508350102/asset/640a3325-27f4-48bf-bf8e-6db4c0b20b50/assets/graphic/zpq0480503120001.jpeg)
Leucine-rich repeat kinase 2: A new player with a familiar theme for Parkinson's disease pathogenesis | PNAS
![The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease | Nature Reviews Neuroscience The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease | Nature Reviews Neuroscience](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrn2935/MediaObjects/41583_2010_Article_BFnrn2935_Fig1_HTML.jpg)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease | Nature Reviews Neuroscience
![The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4 | Scientific Reports The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4 | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-40808-y/MediaObjects/41598_2019_40808_Fig1_HTML.png)
The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4 | Scientific Reports
![The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4 | Scientific Reports The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4 | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-40808-y/MediaObjects/41598_2019_40808_Fig1_HTML.png)
The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4 | Scientific Reports
![PDF] Exploring the Role of Parkinson's-Linked Leucine-Rich Repeat Kinase-2 in the Immune System | Semantic Scholar PDF] Exploring the Role of Parkinson's-Linked Leucine-Rich Repeat Kinase-2 in the Immune System | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/19b66809191df60f844fdbaf69ede259b3d4da3a/42-Table1.6-1.png)
PDF] Exploring the Role of Parkinson's-Linked Leucine-Rich Repeat Kinase-2 in the Immune System | Semantic Scholar
![RCSB PDB - 2ZEJ: Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase RCSB PDB - 2ZEJ: Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase](https://files.rcsb.org/pub/pdb/validation_reports/ze/2zej/2zej_multipercentile_validation.png)
RCSB PDB - 2ZEJ: Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase
![Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2 | PNAS Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2 | PNAS](https://www.pnas.org/cms/10.1073/pnas.2100844118/asset/55eb4ee1-c65b-4462-857b-8a9b9d7f4d1d/assets/images/large/pnas.2100844118fig01.jpg)
Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2 | PNAS
![IJMS | Free Full-Text | Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells IJMS | Free Full-Text | Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells](https://www.mdpi.com/ijms/ijms-21-01890/article_deploy/html/images/ijms-21-01890-g001.png)
IJMS | Free Full-Text | Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells
![PDF] Identification & characterization of leucine-rich repeat kinase 2 & parkin RBR E3 ubiquitin protein ligase variants in patients with Parkinson's disease by Tamali Halder, Shiv Prakash Verma, Janak Raj, Sharad Pandey, PDF] Identification & characterization of leucine-rich repeat kinase 2 & parkin RBR E3 ubiquitin protein ligase variants in patients with Parkinson's disease by Tamali Halder, Shiv Prakash Verma, Janak Raj, Sharad Pandey,](https://og.oa.mg/Identification%20%26%20characterization%20of%20leucine-rich%20repeat%20kinase%202%20%26%20parkin%20RBR%20E3%20ubiquitin%20protein%20ligase%20variants%20in%20patients%20with%20Parkinson's%20disease.png?author=%20Tamali%20Halder,%20Shiv%20Prakash%20Verma,%20Janak%20Raj,%20Sharad%20Pandey,%20Ranjeet%20Kumar%20Singh,%20Vivek%20Sharma,%20Deepika%20Joshi,%20Parimal%20Das)
PDF] Identification & characterization of leucine-rich repeat kinase 2 & parkin RBR E3 ubiquitin protein ligase variants in patients with Parkinson's disease by Tamali Halder, Shiv Prakash Verma, Janak Raj, Sharad Pandey,
![LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review | Journal of Biomedical Science | Full Text LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review | Journal of Biomedical Science | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12929-018-0454-0/MediaObjects/12929_2018_454_Fig1_HTML.png)
LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review | Journal of Biomedical Science | Full Text
![The First CACHE Challenge – Identifying Binders of the WD-Repeat Domain of Leucine-Rich Repeat Kinase 2 | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage The First CACHE Challenge – Identifying Binders of the WD-Repeat Domain of Leucine-Rich Repeat Kinase 2 | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage](https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/62ec286badfd353fe6270e34/largeThumb/the-first-cache-challenge-identifying-binders-of-the-wd-repeat-domain-of-leucine-rich-repeat-kinase-2.jpg)